However, traditional strategies for early diagnosis and screening of GC rely on serum tumor markers, imaging, and endoscopy, including carcinoembryonic antigen (CEA), CA19–9, CA125, and other [[11], [12], [13]]. The gene discussed is CEACAM5; the disease is neoplasm.